Dosage and administration
Apply liberally 15 minutes before sun exposure Reapply: After 40 minutes of swimming or sweating Immediately after towel drying At least every 2 hours Children under 6 months: Ask a doctor
Apply liberally 15 minutes before sun exposure Reapply: After 40 minutes of swimming or sweating Immediately after towel drying At least every 2 hours Children under 6 months: Ask a doctor
Drug Facts
Zinc Oxide (non-nano) 20%
sunscreen
For external use only.
When using this product
Keep out of reach of children.
Purified Water, Organic Aloe Barbadensis Leaf Juice1, Capric/ Caprylic Triglycerides, Sorbitan Stearate, Polyglyceryl-10 Laurate, Cetyl Dimethicone, Magnesium Sulfate, Organic Avocado Oil1, Virgin Hemp Seed Oil, Organic Cucumber Extract1, Organic Green Tea Extract1, Tocopherols, Organic Pomegranate Juice1, Helionori, Hyaluronic Acid, Ethylhexylglycerin, Hydrogenated Methyl Abiate, Polyaminopropyl Biguanide.
1 Certified by a USDA third party agency
High sun protection product.
Call toll free 1-800-798-7970
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55777-0100-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-d36d-a426-e053-dadaa90af4c2 | Burn Out ® SPF-30 Sunscreen |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55777-0100-1 | Burn Out SPF-30 Sunscreen | 100 mL in 1 TUBE | LOTION | 100 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55777-0100 | BURN OUT SPF-30 SUNSCREEN (ZINC OXIDE) LOTION [SUN RESEARCH LLC] | 3 | Legacy NDC, 1 package rows | 20200122_4de75ca6-050d-4ca1-b9af-841a0f9c35ee.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| aloe vera leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| avocado oil | INACTIVE INGREDIENT | 6VNO72PFC1 | 1 | |
| cannabis sativa seed oil | INACTIVE INGREDIENT | 69VJ1LPN1S | 1 | |
| cetyl dimethicone 150 | INACTIVE INGREDIENT | 5L694Y0T22 | 1 | |
| ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| green tea leaf | INACTIVE INGREDIENT | W2ZU1RY8B0 | 1 | |
| hyaluronic acid | INACTIVE INGREDIENT | S270N0TRQY | 1 | |
| hydrogenated methyl abietate | INACTIVE INGREDIENT | A23O709X8O | 1 | |
| magnesium sulfate | INACTIVE INGREDIENT | DE08037SAB | 1 | |
| polihexanide | INACTIVE INGREDIENT | 322U039GMF | 1 | |
| polyglyceryl-10 laurate | INACTIVE INGREDIENT | MPJ2Q8WI8G | 1 | |
| pomegranate juice | INACTIVE INGREDIENT | 99S671U9KB | 1 | |
| sorbitan monostearate | INACTIVE INGREDIENT | NVZ4I0H58X | 1 | |
| tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| tricaprylin | INACTIVE INGREDIENT | 6P92858988 | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 55777-0100 | 55777-0100-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | CREAM / TOPICAL | 177 mg | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | TABLET / ORAL | 0.08 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUSPENSION / TOPICAL | 2.15 %w/w | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET, FILM COATED / ORAL | 14 mg | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | CAPSULE, COATED / ORAL | 0.25 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUSPENSION / ORAL | 62.5 mg/5ml | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | CREAM / VAGINAL | 100 mg | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | CAPSULE / ORAL | NA | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | CAPSULE / ORAL | NA | ||
| tricaprylin | TRICAPRILIN | 6P92858988 | INJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL | 1 mg | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SPRAY / TOPICAL | 4.58 %w/w | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | OINTMENT / TOPICAL | NA | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | SOAP / TOPICAL | 0.2 %w/w | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | LOTION / TOPICAL | 89 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUPPOSITORY / VAGINAL | NA | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | AEROSOL, FOAM / TOPICAL | 0.55 %w/w | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | CREAM / TOPICAL | NA | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | INJECTION, EMULSION / INTRAVENOUS | 0.02 %w/v | ||
| tricaprylin | TRICAPRILIN | 6P92858988 | INJECTABLE, LIPOSOMAL / INFILTRATION | 0.2 %w/v | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SOLUTION / TOPICAL | NA | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | TABLET / ORAL | 4 mg | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET, COATED / ORAL | NA | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET / ORAL | 2.9 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c5557681-f4ae-461b-91d3-80f6c741dcac | 4de75ca6-050d-4ca1-b9af-841a0f9c35ee | 2020-01-21 | Warnings | c5557681-f4ae-461b-91d3-80f6c741dcac 4de75ca6-050d-4ca1-b9af-841a0f9c35ee |
Adverse event summaries are temporarily unavailable. Other product information remains available.